Cargando…
COX-2-PGE(2)-EPs in gynecological cancers
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXibs) inhibit the progression of endometrial cancer, ovarian cancer and cervical cancer. However, concerning the adverse effects of NSAIDs and COXibs, it is still urgent and necessary to explore novel and specif...
Autores principales: | Ye, Yao, Wang, Xipeng, Jeschke, Udo, von Schönfeldt, Viktoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246249/ https://www.ncbi.nlm.nih.gov/pubmed/32363546 http://dx.doi.org/10.1007/s00404-020-05559-6 |
Ejemplares similares
-
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
por: Ye, Yao, et al.
Publicado: (2020) -
Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients
por: Zhu, Junyan, et al.
Publicado: (2017) -
Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage
por: Peng, Lin, et al.
Publicado: (2021) -
The role of PGE(2) EP(4) receptors in the regulation of endothelial barrier function
por: Kampitsch, Nora, et al.
Publicado: (2012) -
The COX-2/PGE(2)/EP3/G(i/o)/cAMP/GSIS Pathway in the Islet: The Beat Goes On
por: Robertson, R. Paul
Publicado: (2017)